As part of its strategy for international integration and global expansion, from August 27 to 29, 2025, a senior delegation from Ben Tre Pharmaceutical Joint Stock Company (Bepharco) successfully participated in the CPHI Korea 2025 International Pharmaceutical Exhibition, held at the COEX Convention and Exhibition Center in Seoul, South Korea.

Bepharco’s presence at one of Asia’s most prestigious and large-scale pharmaceutical events once again underscored the company’s strong position and ambition within the global pharmaceutical landscape.

CPHI Korea – A Global Gathering of Pharmaceutical Excellence

CPHI Korea is an annual exhibition that brings together hundreds of enterprises and thousands of leading global experts in the pharmaceutical field. The event spans the entire pharmaceutical supply chain—from research and development, active pharmaceutical ingredient (API) manufacturing, pharmaceuticals and biologics, contract development and manufacturing services (CDMO, CMO), to machinery, equipment, and biotechnology.
More than just a trade exhibition, it is a prestigious scientific forum where companies stay abreast of the latest technological trends, seek strategic partnerships, and expand their business networks across promising markets.

Bepharco’s Objectives and Activities at the Event

With the strategic goal of strengthening international cooperation and pursuing sustainable growth opportunities, Bepharco actively participated in CPHI Korea 2025 through key initiatives:

• Partner Engagement: Meeting and engaging directly with leading global suppliers of raw materials, pharmaceutical and biological manufacturers, and providers to secure high-quality sources and diversify its product portfolio.
• Exploring Collaboration Opportunities: Discussing potential partnerships in manufacturing, licensing, technology transfer, and product distribution, particularly for innovative products incorporating advanced scientific breakthroughs.
• Showcasing Capabilities: Presenting Bepharco’s strengths and resources—including state-of-the-art facilities and an extensive nationwide distribution network—to affirm the company’s credibility and position with international partners.
• Tracking Industry Trends: Gaining insights into the latest global pharmaceutical developments, from advanced formulation technologies to updated regulatory and quality management standards.

Affirming Position – Shaping the Future

Bepharco’s successful participation in CPHI Korea 2025 concluded on a high note, opening up numerous promising partnership opportunities and providing valuable insights to guide the company’s future development strategies. This achievement marks an important milestone in Bepharco’s journey toward becoming one of Vietnam’s leading pharmaceutical enterprises and expanding its regional presence.

Bepharco extends its sincere gratitude to our esteemed partners and customers for their trust and support. We remain committed to continuous innovation, integration, and dedication to delivering high-quality pharmaceutical products and healthcare services, contributing to the mission of safeguarding and improving public health.